+948.4%
MRNA vs XME
+208.4%
+740.0%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | XME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -5.9% | +3.8% | 0.0% |
| 7D | -12.7% | -14.3% | +1.6% | -7.5% |
| 30D | -20.7% | -20.7% | +0.1% | -13.2% |
| 3M | +46.3% | -29.9% | +76.2% | +67.1% |
| 6M | +305.2% | -29.0% | +334.2% | +363.9% |
| YTD | +561.2% | -22.3% | +583.6% | +640.6% |
| 1Y | +772.1% | -7.9% | +780.0% | +836.9% |
| 3Y | +147.0% | +54.8% | +92.2% | +136.6% |
| 5Y | -26.1% | +91.0% | -117.1% | -30.1% |
| All | +948.4% | +208.4% | +740.0% | +989.5% |
Cumulative growth
Daily Returns
Daily percentage return beside XME.
Daily Out/Under-Performance
Portfolio return minus XME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × XME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded XME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling